Clinical Trial Update: Cyclosporine on Day Zero as Prophylaxis for Cytokine Release Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Day 0 cyclosporine as prophylaxis for cytokine release syndrome in stem cell transplant settings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytokine Release Syndrome
• Stem Cell Transplant Complications

Snippet

Sponsor: Hospital Universitario Dr. Jose E. Gonzalez | Conditions: Stem Cell Transplant Complications, Cytokine Release Syndrome | Phase 2 | Status: UNKNOWN